Glaucoma Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People aged 18 to 85 years old (male or female)
• People diagnosed with primary open-angle glaucoma where eye pressure is not well controlled even while taking the maximum amount of glaucoma medications that can be tolerated, and whose eye pressure measures between 18 mmHg and 35 mmHg while on those medications
• People who are willing to follow all study requirements throughout the trial
• People who have signed the official consent form approved for this study

Who may not be able to join:

• People who have angle-closure glaucoma (a different type of glaucoma)
• People who have scarring on the clear tissue covering the white of the eye, have had eye surgery involving that tissue, or have conditions affecting that tissue (such as a growth called a pterygium, or very thin tissue)
• People who have active abnormal blood vessel growth on the coloured part of the eye
• People who have an active eye infection or inflammation, such as eyelid inflammation, pink eye, or inflammation inside the eye
• People who have gel from inside the eye that has moved into the front chamber of the eye
• People who have a certain type of artificial lens implanted at the front of the eye
• People who have silicone oil inside the eye
• People who need glaucoma surgery combined with other eye procedures (such as cataract surgery), or who are expected to need additional eye surgery during the study period
• People whose central corneal thickness (the thickness of the clear front surface of the eye) is less than 450 microns or greater than 620 microns
• People who have previously had a procedure to reduce pressure by treating the ciliary body (the part of the eye that produces fluid)
• People who have neovascular glaucoma (a type caused by abnormal blood vessel growth)
• People who have uveitic glaucoma (a type caused by eye inflammation)
• People who have pseudoexfoliative or pigmentary glaucoma (two other specific types of glaucoma)
• People who have chronic (long-term) inflammation
• People who have had incisional eye surgery within the 6 months before the study
• People currently enrolled in another clinical study, or who have recently completed another study within 30 days of the screening appointment (also, only one eye per person may participate in this study)
• People whose overall eye health or medical condition, in the treating doctor's judgement, could increase the risk of complications or interfere with safe participation in the trial (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.